Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
Trypanosoma cruzi is the causal agent of Chagas Disease that is endemic in Latin American, afflicting more than ten million people approximately. This disease has two phases, acute and chronic. The acute phase is often asymptomatic, but with time it progresses to the chronic phase, affecting the hea...
Main Authors: | Carolina Campos-Estrada, Ana Liempi, Fabiola González-Herrera, Michel Lapier, Ulrike Kemmerling, Barbara Pesce, Jorge Ferreira, Rodrigo López-Muñoz, Juan D Maya |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-05-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4433340?pdf=render |
Similar Items
-
Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.
by: Alfredo Molina-Berríos, et al.
Published: (2013-01-01) -
Lipid-Derived Mediators in Endogenous Anti-Inflammation and Resolution: Lipoxins and Aspirin-Triggered 15-epi-Lipoxins
by: Charles N. Serhan, et al.
Published: (2002-01-01) -
A High-Fat Diet Exacerbates the Course of Experimental Trypanosoma cruzi Infection That Can Be Mitigated by Treatment with Simvastatin
by: Débora Maria Soares de Souza, et al.
Published: (2020-01-01) -
Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics.
by: Andrea Trochine, et al.
Published: (2014-05-01) -
Simvastatin-Loaded Nanomicelles Enhance the Osteogenic Effect of Simvastatin
by: Xianling Feng, et al.
Published: (2020-01-01)